So, Medtronic is shaking things up, especially with their diabetes division. They’re planning to split it off into its own ...

Medtronic (NYSE:MDT) today announced new milestones for its Affera family of technologies, including FDA breakthrough device ...

Medtronic (NYSE:MDT) today announced new clinical findings supporting its Aurora EV-ICD system and OmniaSecure defibrillation ...

The FDA has classified a corrective action for Tandem Diabetes Care’s Mobi insulin pumps as a Class I recall, its highest ...

The U.S. Food and Drug Administration has classified a corrective action involving insulin pumps from Tandem Diabetes Care ...

Sedentary behaviour is associated with an increased risk of cardiovascular disease and all-cause mortality in people with ...

As quantum computers advance, they are expected to be able to break tried-and-true security schemes that currently keep most ...

Medtronic launches Adaptive DBS in India, offering real‑time Parkinson’s therapy with BrainSense™ to improve patient quality ...

Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global ...

A malfunction may cause insulin delivery to stop. Tandem instructed users to update their pump software as soon as possible.

Report OverviewThe global insulin pumps market is projected to grow at a rate of 12% by 2028, fueled by rising diabetes ...

As technology becomes more integrated and personalized, experts say the biggest opportunity in diabetes management is ...